BELITE BIO INC - ADR Share Price Today: Live Updates & Key Insights

BELITE BIO INC - ADR share price today is $153.5, up -1.87%. The stock opened at $154.81 against the previous close of $156.28, with an intraday high of $155.75 and low of $152.36.

BELITE BIO INC - ADR Share Price Chart

BELITE BIO INC - ADR

us-stock
To Invest in {{usstockname}}
us-stock

BELITE BIO INC - ADR Share Price Performance

$153.5 -0.0187(-1.87%) BLTE at 27 Jul 2026 02:13 PM Biotechnology
Lowest Today 152.36
Highest Today 155.75
Today’s Open 154.81
Prev. Close 156.28
52 Week High 200.00
52 Week Low 60.00
Day’s Range: Low 152.36 High 155.75
52-Week Range: Low 60.00 High 200.00
1 day return -
1 Week return +0.09
1 month return +2.77
3 month return -5.82
6 month return -5.5
1 year return +148.26
3 year return +727.93
5 year return -
10 year return -

BELITE BIO INC - ADR Institutional Holdings

Darwin Global Management, Ltd. 7.63

Paradigm Biocapital Advisors LP 2.78

UBS Group AG 1.92

RTW INVESTMENTS, LLC 1.78

Millennium Management LLC 1.42

Holocene Advisors, LP 1.23

Eventide Asset Management, LLC 0.89

Eventide Healthcare & Life Sciences I 0.89

Deerfield Management Co 0.76

T. Rowe Price Associates, Inc. 0.70

Morgan Stanley - Brokerage Accounts 0.50

Perceptive Advisors LLC 0.38

Patient Square Capital LP 0.29

MEDICAL BioHealth EUR Acc 0.28

Duquesne Family Office LLC 0.26

The Goldman Sachs Group Inc 0.26

MPM Oncology Impact Management LP 0.22

HBM Healthcare Investments AG Ord 0.20

Affinity Asset Advisors, LLC 0.16

Fred Alger Management, LLC 0.16

Alger Small Cap Focus Composite 0.15

Alger Small Cap Focus I 0.15

Partner Fund Management LP 0.15

Renaissance Technologies Corp 0.13

Longaeva Partners L.P. 0.08

apo Medical Opportunities R 0.06

BrighthouseI Morgan Stanley Discovery B 0.04

RIM Global Bioscience EUR 0.03

State Street® SPDR® Portfolio EM ETF 0.03

Morgan Stanley Discovery 0.03

Morgan Stanley Inst Discovery I 0.03

Fidelity Nasdaq Composite Index 0.02

Fidelity ZERO International Index 0.01

MS INVF Global Endurance Z USD Acc 0.01

Fidelity® SAI Em Mkts Momt Idx Fd 0.01

ActivePassive International Equity ETF 0.01

Fidelity Nasdaq Composite ETF 0.01

Fidelity Select Biotechnology 0.01

State Street® SPDR® S&P® China ETF 0.01

Morgan Stanley VIF Discovery I 0.01

BELITE BIO INC - ADR Market Status

Strong Buy: 3

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

BELITE BIO INC - ADR Fundamentals

Market Cap 6298.97 M

PB Ratio 7.8549

PE Ratio 0.0

Enterprise Value 5758.88 M

Total Assets 780.56 M

Volume 172383

BELITE BIO INC - ADR Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M

Annual Net worth FY23:-31426000 -31.4M, FY22:-12475000 -12.5M, FY21:-9792000 -9.8M, FY20:-5753000 -5.8M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:null 0.0M, Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M

Quarterly Net worth Q1/2026:-26938000 -26.9M, Q3/2025:-21690000 -21.7M, Q2/2025:-16320000 -16.3M, Q1/2025:-14277000 -14.3M, Q3/2024:-8679000 -8.7M

About BELITE BIO INC - ADR & investment objective

Company Information Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States. Its lead product candidate is Tinlarebant (LBS-008), an orally administered, which is in phase 3 clinical trial as an early intervention for maintaining the health and integrity of retinal tissues in stargardt disease type 1 and geographic atrophy patients. The company also develops LBS-009, an retinol binding protein 4 oral therapy, which is in preclinical development targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, as well as gout. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.

Organisation Biotechnology

Employees 41

Industry Biotechnology

CEO Dr. Yu-Hsin Lin M.B.A., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BELITE BIO INC - ADR FAQs

What is the share price of BELITE BIO INC - ADR today?

The current share price of BELITE BIO INC - ADR is $153.5.

Can I buy BELITE BIO INC - ADR shares in India?

Yes, Indian investors can buy BELITE BIO INC - ADR shares by opening an international trading and demat account with Motilal Oswal.

How to buy BELITE BIO INC - ADR shares in India?

You can easily invest in BELITE BIO INC - ADR shares from India by:

Can I buy fractional shares of BELITE BIO INC - ADR?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BELITE BIO INC - ADR?

BELITE BIO INC - ADR has a market cap of $6298.97 M.

In which sector does BELITE BIO INC - ADR belong?

BELITE BIO INC - ADR operates in the Biotechnology sector.

What documents are required to invest in BELITE BIO INC - ADR stocks?

To invest, you typically need:

What is the PE and PB ratio of BELITE BIO INC - ADR?

The PE ratio of BELITE BIO INC - ADR is N/A and the PB ratio is 7.85.